Patents Assigned to AGGAMIN PHARMACEUTICALS, LLC
  • Publication number: 20140065150
    Abstract: Disclosed are methods and apparatuses for treating a pregnancy related hypertensive disorder, such as pre-eclampsia and eclampsia, using ex vivo treatment with an anti-sFlt-1 receptor (sFlt-1) antibody bound to a solid support in order to reduce blood levels of sFlt-1. Further disclosed are the sequences of the heavy chain and light chain CDRs of the anti-sFlt-1 antibodies.
    Type: Application
    Filed: February 7, 2012
    Publication date: March 6, 2014
    Applicant: AGGAMIN PHARMACEUTICALS, LLC
    Inventors: Paul Kussie, Woo S. Joo